You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Arterial Doppler for Flow Mediated Reserve measurement
  • Paris, France
    INstitut Mutualiste Montsouris
Aug 29, 2023

Immune Checkpoint Inhibitor-related Cardiotoxicity

Not yet recruiting
  • Immune Checkpoint Inhibitors, Cardiotoxicity
  • Cardiac magnetic resonance
  • (no location specified)
Nov 10, 2023

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

    Recruiting
    • Immunotherapy
    • +5 more
    • blood retriewal
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Apr 3, 2023

    Troponin to Detect Major Cardiovasculaire Advserse Events on

    Recruiting
    • Cancer
    • +2 more
    • No intervention
    • Paris, France
      Institut Mutualiste Montsouris
    Aug 22, 2023

    Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

    Completed
    • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
    • Wenzhou, Zhejiang, China
      The First Affiliated Hospital of Wenzhou Medical University
    Nov 6, 2023

    NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

    Not yet recruiting
    • NSCLC Associated With Leptomeningeal Metastases
    • Tislelizumab, pemetrexed
    • (no location specified)
    Nov 21, 2023

    CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

    Completed
    • Paraneoplastic Syndromes
    • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 11, 2023

    Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

    Not yet recruiting
    • Cervical Cancer
    • Cervical Carcinoma
    • Guangzhou, China
      Sun Yat-sen University Cancer Cetntre
    Apr 9, 2023

    Lung Cancer Trial in Wuhan (Pirfenidone)

    Recruiting
    • Lung Cancer
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Mar 24, 2023

    Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

    Recruiting
    • Immune Checkpoint Inhibitor
    • +3 more
    • Blood sample
    • Amiens, France
      CHU Amiens
    Dec 8, 2022

    EXploring Immune-related Adverse Events of Immune checkpoinT

    Active, not recruiting
    • Cancer
    • +2 more
    • Immune checkpoint inhibitor
    • Paris, France
    • +1 more
    Jul 5, 2023

    Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

    Not yet recruiting
    • Breast Cancer
    • Contrast Enhanced Ultrasound
    • Hershey, Pennsylvania
      Penn State Health College of Medicine
    Jul 19, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 20, 2022

    Uterine Cervical Tumors, Cancer of Cervix, Cervical Cancer Trial (Cadonilimab, Nab paclitaxel)

    Not yet recruiting
    • Uterine Cervical Neoplasms
    • +5 more
    • (no location specified)
    Apr 9, 2023

    Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Anlotinib and TQB2450
    • Shanghai, Shanghai, China
      Zhongshan hospital
    Sep 4, 2023

    Immune Checkpoint Inhibitors in Genitourinary Malignancies

    Suspended
    • Carcinoma, Renal Cell
    • Carcinoma, Urothelial
    • Immune cell and CTC detection procedures
    • Durham, North Carolina
      Duke University Medical Center
    Nov 11, 2022

    Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Immune signature in serum associated to the metabolic signature
    • Meta-genomic signature of intestinal flora
    • La Tronche, Isère, France
      University Hospital, Grenoble
    Jan 6, 2023

    Solid Tumor Trial in Ann Arbor (Potato starch)

    Suspended
    • Solid Tumor
    • Potato starch
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Oct 10, 2022

    SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

    Recruiting
    • SCLC,Extensive Stage
    • Thoracic radiotherapy
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 14, 2022

    Pre-transplant ICI Exposure and Post-transplant Graft Rejection

    Recruiting
    • Graft Rejection
    • +3 more
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
    Jun 21, 2023